Gray Mary ANN
SEC-identified person · CIK 1261974 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Keros Therapeutics, Inc. KROS | Director | filed 2020 - 2026 |
| Rapt Therapeutics, Inc. RAPT | Director | filed 2019 - 2026 |
| Olivia Ventures, Inc. CMPX | Director | filed 2022 - 2026 |
| Bioatla, Inc. BCAB | Director | filed 2020 - 2025 |
| Seneca Biopharma, Inc. SNCA | Director | filed 2019 - 2023 |
| Sarepta Therapeutics, Inc. SRPT | Director | filed 2018 - 2022 |
| Senomyx INC SNMX | Director | filed 2010 - 2018 |
| Juniper Pharmaceuticals INC cbrx | Director | filed 2016 - 2018 |
| Sellas Life Sciences Group, Inc. gale | Director | filed 2016 - 2017 |
| Acadia Pharmaceuticals INC ACAD | Director | filed 2006 - 2016 |
| Dyax Corp DYAX | Director | filed 2006 - 2016 |
| Tetralogic Pharmaceuticals Corp TLOG | Director | filed 2014 - 2015 |
| GTC Biotherapeutics INC GTCB | Director | filed 2007 - 2008 |
| Telik INC TELK | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.